|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | |
| A61K 47/10 | |||
| A61K 47/44 | |||
| A61K 31/573 |
| (11) | Number of the document | 3389631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16810067.5 |
| Date of filing the European patent application | 2016-11-30 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/057227 |
| Date | 2016-11-30 |
| (87) | Number | WO 2017/103719 |
| Date | 2017-06-22 |
| (30) | Number | Date | Country code |
| 201562267749 P | 2015-12-15 | US |
| (72) |
GAUTHIER, Robert T., US
HAMMER, James D., US
|
| (73) |
Therapeutics, Inc.,
9025 Balboa Avenue, Suite 100, San Diego, CA 92123,
US
|
| (54) | HALOBETASOL FOAM COMPOSITION AND METHOD OF USE THEREOF |
| HALOBETASOL FOAM COMPOSITION AND METHOD OF USE THEREOF |